Month: June 2018
-
University Tissue, Cell Fabrication Lab Set to Open
A laboratory for producing new types of biomaterials is scheduled to open next year on the University of Illinois campus in Urbana.
-
Bloodless Glucose Monitoring Technology in Development
An engineering lab in Canada is developing a system that adapts radar technology to measure blood glucose levels, to eventually replace the blood drop samples now used by people with diabetes.
-
NIH Grant Funds New Spinal Cord Injury Treatment
A biotechnology company developing regenerative therapies for neurological disorders is receiving a Small Business Innovation Research grant to advance an experimental treatment for spinal cord injury.
-
Are You Investing Sensibly? Find Out by Reading On
Think about what you can do to improve your future financial situation by making the best possible investments.
-
Robotics, A.I. Employed for Personal Autism Therapy
An engineering lab at MIT developed techniques for combining robotics with deep learning, a form of artificial intelligence, to personalize autism therapy.
-
Agriculture Group Adapts Satellite Imaging, A.I., Big Data
An international agricultural network is partnering with a private company to boost the group’s capabilities in satellite imaging, big data analytics, and artificial intelligence.
-
Engineered Polio Virus Tested as Brain Cancer Treatment
Results of a clinical trial show a genetically engineered polio virus helps more people with glioblastoma, an aggressive form of brain cancer, survive for longer periods.
-
Here’s What Neuroplasticity Means for You
It’s this malleability of the brain that we know as neuroplasticity.
-
Insulin Formulated as Liquid for Capsule Delivery
An bioengineering team created a process to formulate insulin, needed regularly by people with diabetes, as a liquid, to be taken in capsules rather than injections.
-
Cannabis Drug Approved by FDA for Rare, Severe Seizures
A drug based on chemicals derived from cannabis plants was approved by Food and Drug Administration for marketing in the U.S. to treat seizures associated with two rare and severe forms of epilepsy.